{
  "type": "hyp",
  "text": "Mobility shift assays showed that addition of anti-AIM mAb to PMA-treated T lymphocytes markedly enhanced the binding activity of AP-1 to its cognate site the phorbol ester response element.\n",
  "self": {
    "NER": {
      "answers": [
        "AP-1"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the cognate site of the phorbol ester response element?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Mobility shift assays",
        "addition",
        "anti-AIM mAb",
        "the binding activity",
        "AP-1",
        "its cognate site",
        "the phorbol ester response element"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What showed that adding anti-AIM mAb to PMA-treated T lymphocyte",
          "What did mobility shift assays show enhanced the binding activity of AP-1 to its cogn",
          "What did mobility shift assays show to enhance the binding activity of AP-1?",
          "What did the addition of anti-AIM mAb to PMA-treated T lymph",
          "What is the cognate site of the phorbol ester response element?",
          "What does AP-1's phorbol ester response element do?",
          "What site does AP-1 have a cognate with?"
        ]
      }
    }
  },
  "asked": {
    "What protein was binded to the phorbol ester response element?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "AP-1",
        "answerability": 0.9101799726486206,
        "ground_truth": {
          "AP-1": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What showed that adding anti-AIM mAb to PMA-treated T lymphocyte": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Mobility shift assays",
        "answerability": 0.98119056224823,
        "ground_truth": {
          "Mobility shift assays": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What did mobility shift assays show enhanced the binding activity of AP-1 to its cogn": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "addition of anti-AIM mAb to PMA-treated T lymphocytes",
        "answerability": 0.8393158912658691,
        "ground_truth": {
          "addition": {
            "bertscore": 0.6308325529098511,
            "f1": 0.2222222222222222
          }
        }
      }
    },
    "What did mobility shift assays show to enhance the binding activity of AP-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "addition of anti-AIM mAb to PMA-treated T lymphocytes",
        "answerability": 0.9593987464904785,
        "ground_truth": {
          "anti-AIM mAb": {
            "bertscore": 0.7545103430747986,
            "f1": 0.4
          }
        }
      }
    },
    "What did the addition of anti-AIM mAb to PMA-treated T lymph": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.7319028377532959,
        "ground_truth": {
          "the binding activity": {
            "bertscore": 0.6831845045089722,
            "f1": 0
          }
        }
      }
    },
    "What does AP-1 have in common with phorbol ester?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "AP-1",
        "answerability": 0.700440526008606,
        "ground_truth": {
          "its cognate sequence": {
            "bertscore": 0.6466441750526428,
            "f1": 0
          }
        }
      }
    },
    "What sequence of AP-1 is a cognate of AIM?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "phorbol ester",
        "answerability": 0.5841023921966553,
        "ground_truth": {
          "the phorbol ester response element": {
            "bertscore": 0.8498370051383972,
            "f1": 0.6666666666666666
          }
        }
      }
    }
  }
}